Five new cancer treatments are in the works and could be available for use as early as 2010, thanks to GlaxoSmithKline, PLC, the world's second largest drug company.The drugs will treat a range of different cancers -- one will be cervical cancer -- and are known as cervarix, pazopanib, promacta, rezonic, and ofatumumab.
"Over the next three years, GSK will make a difference to millions of patients facing cancer," said Glaxo's head of research and development, Moncef Slaoui.
Glaxo's most recent cancer drug is Tykerb, an oral breast cancer treatment launched in March.
